These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6188011)

  • 1. Further advances in the management of malignant teratomas of the testis and other sites.
    Newlands ES; Begent RH; Rustin GJ; Parker D; Bagshawe KD
    Lancet; 1983 Apr; 1(8331):948-51. PubMed ID: 6188011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current optimum management of anaplastic germ cell tumours of the testis and other sites.
    Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
    Br J Urol; 1986 Jun; 58(3):307-14. PubMed ID: 2424538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
    Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Crawford SM; Holden L
    Int J Androl; 1987 Feb; 10(1):301-9. PubMed ID: 2438223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis following chemotherapy for metastatic malignant teratoma.
    Horwich A; Easton D; Husband J; Nicholas D; Peckham MJ
    Br J Urol; 1987 Jun; 59(6):578-83. PubMed ID: 2446691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of disseminated germ cell tumours of the testis.
    Athanassiou A; Pectasides D; Bafaloukos D; Barbounis V; Dimitriadis M; Christodoulou K
    Br J Urol; 1989 May; 63(5):525-30. PubMed ID: 2471573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
    Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
    J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
    Irie T; Watanabe H; Kawaoi A; Takeuchi J
    Cancer; 1982 Sep; 50(6):1160-5. PubMed ID: 6179592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy in the treatment of germ cell tumors containing choriocarcinoma in males and females.
    Goldstein DP; Piro AJ
    Surg Gynecol Obstet; 1972 Jan; 134(1):61-6. PubMed ID: 4332022
    [No Abstract]   [Full Text] [Related]  

  • 10. POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.
    Husband DJ; Green JA
    Eur J Cancer; 1992; 28(1):86-91. PubMed ID: 1373636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
    Horwich A; Brada M; Nicholls J; Jay G; Hendry WF; Dearnaley D; Peckham MJ
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ; Norman AR; Dearnaley DP; Horwich A
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleomycin combination chemotherapy in the management of testicular neoplasia.
    Samuels ML; Holoye PY; Johnson DE
    Cancer; 1975 Aug; 36(2):318-26. PubMed ID: 50869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
    Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
    Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-marker levels and prognosis in malignant teratoma of the testis.
    Germa-Lluch JR; Begent RH; Bagshawe KD
    Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
    Hayashi M; Ebihara K; Urano E
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
    Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
    Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
    Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
    Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
    Skinner DG; Scardino PT
    Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.